Targeted therapy in small cell lung cancer: A new era?
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference12 articles.
1. GLOBOCAN 2012 Version 1.0: Cancer Incidence and Mortality Worldwide—IARC CancerBase No 11;Ferlay,2013
2. Treatment of small-cell lung cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline;Rudin;J. Clin. Oncol.,2015
3. Targeted therapies for small cell lung cancer: where do we stand?;Arcaro;Crit. Rev. Oncol. Hematol.,2015
4. Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer;von Pawel;J. Clin. Oncol.,2014
5. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Fruh;Ann. Oncol.,2013
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The inhibitory effect of apatinib on different small cell lung cancer cells and in lung cancer‐bearing mice and patients;The Clinical Respiratory Journal;2024-02
2. Is time to progression associated with post-progression survival in previously treated metastatic non-small cell lung cancer with BRAF V600E mutation? A secondary analysis of phase II clinical trial data;BMJ Open;2018-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3